Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Multiplās sklerozes iešanas skala-12 (MSWS-12)× | Stroke-Specific Quality of Life Scale (SS-QoL)× | |
|---|---|---|
| Nozare | Neiroloģija | Neiroloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 2003 | 1999 |
| Autors≠ | Jeremy C. Hobart, University of Plymouth | Lee S. Williams, Indiana University |
| Tips | Self-report questionnaire | Self-report questionnaire |
| Pirmavots≠ | Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 60(1), 31-36. DOI ↗ | Williams, L. S., Weinberger, M., Harris, L. E., Clark, D. O., & Biller, J. (1999). Development of a Stroke-Specific Quality of Life Scale. Stroke, 30(7), 1362-1369. DOI ↗ |
| Citi nosaukumi | MS Walking Scale-12, MSWS | Stroke-Specific QoL, SS-QOL |
| Saistītās≠ | 3 | 4 |
| Kopsavilkums≠ | The MSWS-12 is a brief, patient-reported outcome measure specifically designed to assess the impact of multiple sclerosis on walking ability and limitation. Developed by Hobart and colleagues in 2003, this 12-item scale captures both the physical difficulty and functional consequences of MS-related gait impairment. It is highly responsive to change and widely used in MS clinical trials and practice as a primary outcome measure for assessing intervention effects on mobility. | The SS-QoL is a disease-specific quality-of-life instrument designed to capture the multidimensional impact of stroke on survivors' functional and emotional well-being. Developed by Williams and colleagues in 1999, this 49-item scale addresses stroke-specific concerns including language, cognition, mobility, and emotional functioning. It is a gold-standard instrument for stroke outcome research and routine clinical monitoring of post-stroke recovery. |
| ScholarGateDatu kopa ↗ |
|
|